Renin-angiotensin system and cancer: epidemiology, cell signaling, genetics and epigenetics
- 15 September 2020
- journal article
- review article
- Published by Springer Science and Business Media LLC in Clinical and Translational Oncology
- Vol. 23 (4), 682-696
- https://doi.org/10.1007/s12094-020-02488-3
Abstract
Day by day, the health and economical burden of cancer increases globally. Indeed it can be considered that there is ‘’cancer pandemic’’. Blocking the renin-angiotensin system (RAS) by angiotensin-converting enzyme (ACE) inhibitors (ACEI) or angiotensin-receptor blockers (ARB) are widely used measures to treat hypertension and heart failure. It has been recently suggested the activation and blocking of RAS has been associated with various types of cancer in epidemiological and experimental studies. Various studies have shown that RAS blockage is protective in some cancers. However, although fewer, contradictory data also showed that RAS blockage is either not related or adversely related to cancer. Although the reasons for these findings are not exactly known, different types of receptors and effectors in RAS may account for these findings. In the current review, we summarize the different RAS receptors and cancer development with regard to epidemiology, and pathogenesis including cell signaling pathways, apoptosis, genetic and epigenetic factors.Keywords
This publication has 116 references indexed in Scilit:
- The shaping and functional consequences of the microRNA landscape in breast cancerNature, 2013
- miR-141 and miR-200a act on ovarian tumorigenesis by controlling oxidative stress responseNature Medicine, 2011
- MicroRNAs and developmental timingCurrent Opinion in Genetics & Development, 2011
- Association between polymorphisms of the renin–angiotensin system genes and breast cancer risk: a meta-analysisBreast Cancer Research and Treatment, 2011
- NF-κB addiction and its role in cancer: ‘one size does not fit all’Oncogene, 2010
- MiR-21 is an EGFR-regulated anti-apoptotic factor in lung cancer in never-smokersProceedings of the National Academy of Sciences of the United States of America, 2009
- AGTR1 overexpression defines a subset of breast cancer and confers sensitivity to losartan, an AGTR1 antagonistProceedings of the National Academy of Sciences of the United States of America, 2009
- Human microRNA-155 on Chromosome 21 Differentially Interacts with Its Polymorphic Target in the AGTR1 3′ Untranslated Region: A Mechanism for Functional Single-Nucleotide Polymorphisms Related to PhenotypesAmerican Journal of Human Genetics, 2007
- Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in Eμ-miR155 transgenic miceProceedings of the National Academy of Sciences of the United States of America, 2006
- MicroRNA expression profiles classify human cancersNature, 2005